Table 2.
Univariate Analysis | |||
---|---|---|---|
OR | 95% CI | p | |
MC+ | 6.52 | 1.27–33.45 | 0.02 |
Age | 1.05 | −0.01–0.12 | 0.09 |
Sex | 0.50 | −2.03–0.67 | 0.32 |
HCV-RNA | 1.00 | −8.30 × 10−7–1.98 × 10−7 | 0.22 |
HBV | 1.58 | 0.39–6.30 | 0.52 |
Diabetes | 2.35 | −0.75–2.46 | 0.29 |
Steatosis | 1.22 | −1.12–1.53 | 0.76 |
Cirrhosis | 4.72 | 0.91–24.60 | 0.06 |
Hematologic diseases |
1.33 | −2.09–2.66 | 0.81 |
Presence of plasma cells | 0.46 | −3.26–1.73 | 0.54 |
N° plasma cells/hotspot 40X | 1.05 | 0.01–0.08 | 0.004 |
Plasma cell aggregates |
2.65 | −0.36–2.32 | 0.15 |
Multivariate analysis | |||
OR | 95% CI | p | |
MC+ | 8.30 | 1.16–61.82 | <0.05 |
Age | 1.1 | 0.95–1.16 | 0.31 |
HCV-RNA | 1.00 | 1.00–1.00 | 0.95 |
Diabetes | 2.02 | 0.27–14.84 | 0.49 |
Cirrhosis | 1.50 | 0.20-11.14 | 0.68 |